- 美国卫生部长小罗伯特·F·肯尼迪(Robert F. Kennedy Jr.)大幅修改了联邦疫苗咨询机构——疾控中心免疫实践咨询委员会(ACIP)的章程。新章程赋予他更大权力任命与其观点一致的顾问,并将委员会关注重点转向所谓疫苗伤害与风险。章程还允许边缘团体和反疫苗组织参与CDC事务。此次修改取代了常规的两年一次例行续期程序,实质性地改变了该机构在联邦疫苗政策中的职能方向。
卫生部长修改疫苗顾问委员会章程
扩大任命权并聚焦疫苗风险议题
反疫苗组织获准参与CDC事务
- 新章程要求ACIP成员“考虑疫苗及其成分累积效应的分析”,这一表述呼应反疫苗阵营长期主张,即将过敏、自闭症等复杂病症归因于多种疫苗或常见成分(如铝佐剂)的叠加作用。此举标志着从过去针对单一疫苗(如麻疹疫苗与自闭症关联)的指控,转向更广泛的系统性归责。尽管相关说法已被大量高质量研究证伪,但新任务仍可能影响政策制定与公众认知。
新增疫苗累积效应分析职责
呼应反疫苗群体核心主张
可能误导公众对疫苗安全认知
- 章程明确将mRNA疫苗纳入ACIP重点监控范围。尽管mRNA疫苗本就属于该委员会职责范畴,但因其在新冠疫情期间广泛应用而遭到肯尼迪及其支持者强烈反对。肯尼迪曾错误宣称mRNA新冠疫苗是“史上最致命疫苗”。此次特别强调监控,反映出政治立场对科学 advisory 机构议程的直接影响。
mRNA疫苗被设为特别监控对象
反映卫生部长个人政治立场
科学 advisory 机构独立性受挑战
- U.S. Health Secretary Robert F. Kennedy Jr. has significantly revised the charter of the CDC’s Advisory Committee on Immunization Practices (ACIP), a federal panel that shapes national vaccine policy. The updated charter, published in the Federal Register on Thursday, grants Kennedy greater authority to appoint members aligned with his views and refocuses the committee’s mission on vaccine safety concerns favored by anti-vaccine advocates. Key changes include new responsibilities such as analyzing the “cumulative effects of vaccines and their constituent components,” a concept frequently promoted by anti-vaccine groups to link vaccines to conditions like autism and allergies—claims unsupported by scientific consensus. The revised charter also emphasizes monitoring mRNA vaccines, which Kennedy has previously criticized with unfounded claims, including calling the mRNA COVID-19 vaccine “the deadliest vaccine ever made.” These changes mark a departure from ACIP’s traditional role in evaluating vaccine efficacy and public health benefits, shifting toward a risk-focused framework. The move is expected to influence state-level immunization requirements and insurance coverage decisions, potentially undermining public confidence in routine vaccinations. Detailed information on specific appointees or immediate policy changes remains limited.
Key Takeaways:
Kennedy rewrites CDC vaccine panel charter to prioritize safety concerns
New focus includes cumulative vaccine effects and mRNA vaccine monitoring
Changes may influence state policies and public trust in vaccines
Detailed information limited on implementation and new appointees
Source: Original Article
查看原文 →
View Original →